In addition, METTL3 promotes malignant growth in IDH wild-type gliomas via the mechanism of enhancing MALAT1 stability through m6A alteration with the aid of HuR and by means of activating NF-κB. The gene discussed is NFKB1; the disease is central nervous system cancer.